Latest Artificial Intelligence News

Page 8 of 107
Spenda reported a sharp quarter-on-quarter improvement in operating cash flow, backed by A$4.2 million in annualised savings and a leaner workforce. But with A$876,000 in cash and an estimated 2.1 quarters of funding at the latest burn rate, the turnaround still has little room for delay.
Victor Sage
Victor Sage
30 Oct 2026
Stakk delivered a second consecutive quarter of positive operating cash flow, reaching A$731,000 as its newly enlarged group reported A$16.075 million in unaudited pro-forma revenue. The more revealing test arrives next quarter, when ParaScript contributes a full period of statutory cash flows while acquisition-related obligations begin to bite.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Decidr AI Industries reported a sharp quarterly fall in its invoicing-based AER, even as customer receipts reached a record and Sugarwork’s qualified pipeline expanded. The company is relying on A$11 million of annualised cost reductions and upcoming product launches to extend its runway and convert enterprise interest into recurring revenue.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Vection Technologies has started FY27 with stronger customer receipts, a sharply narrower operating cash loss and A$7.0 million in quarter-end cash. The next test is whether Defence, Retelit and URBANnext commitments convert into reported revenue through the year.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Algorae Pharmaceuticals has moved closer to its first expected NSW Health supply orders while reporting stronger preclinical results from its AOS2 drug-discovery platform. The company ended September with $3.15 million in cash and a further $3 million undrawn facility, but its commercial contract carries no minimum volume commitment.
Victor Sage
Victor Sage
30 Oct 2026
CAR Group enters FY27 with double-digit growth expectations after reporting A$1.253 billion in pro forma revenue and 100% EBITDA-to-cash conversion for FY26. Its next growth phase centres on AI agents, proprietary vehicle data and new products across its global marketplaces.
Victor Sage
Victor Sage
30 Oct 2026
Hiremii’s revenue fell 11.1% to A$7.056 million in Q1 FY2027 as adjusted EBITDA slipped further into loss, testing the company’s transition towards AI-powered workforce intelligence. The new AQYR brand and two platform launches offer a growth narrative, but cash discipline remains central with A$1.789 million of total available funding.
Victor Sage
Victor Sage
30 Oct 2026
TALi Digital closed its September quarter with $3.9 million in cash after completing a $3.3 million capital raise and winning shareholder approval for the Datasphere transaction. The company has also exercised an option to negotiate exclusive worldwide rights to Technion in-memory computing technology, although the licence remains unsigned and the technology unproven at commercial scale.
Victor Sage
Victor Sage
30 Oct 2026
X2M Connect has raised A$1.4 million through a placement as it shifts capital and management focus towards regional data centres, AI infrastructure and energy management. The move comes after first-quarter revenue fell 34% and the company recorded a larger adjusted EBITDA loss, with a further A$3.6 million rights issue planned.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Novatti’s AU/NZ quarterly transaction value rose to $1.2 billion, but regulatory disruption to international BPAY payments pushed revenue lower and left Cash EBITDA negative. The company is targeting an early 2027 relaunch while relying on pipeline conversion and product mix improvements to support its next phase of growth.
Claire Turing
Claire Turing
30 Oct 2026
Barramundi’s portfolio suffered its worst reported year in decades, with a NZ$42.9 million loss and an adjusted NAV return of -18.2% against a 9.2% benchmark gain. The board is negotiating a new management agreement with Fisher Funds while imposing tighter diversification and risk limits.
Claire Turing
Claire Turing
30 Oct 2026
Clever Culture Systems has started FY27 with three APAS Independence sales to Novo Nordisk and AstraZeneca, while targeting eight first-half sales and evaluations. The sales momentum comes with $1.6 million of unsecured loans due in December and a proposed extension still to be secured.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive